Dublin-based clinical research organization ICON Public Limited Company is a leading provider of outsourced development and commercialization services across the globe. The company specializes in the strategic management and analysis of programs supporting various phases of the clinical development process, from compound selection to Phase I-IV clinical studies. Their services include clinical development services, clinical research services, and laboratory services. The company also offers commercial positioning, early phase, language, medical imaging, and strategic solutions, as well as clinical trial management, consulting, and contract staffing services. ICON Public Limited Company caters to a wide range of industries, including pharmaceutical, biotechnology, and medical device, as well as government and public health organizations. Since its incorporation in 1990, the company has expanded its operations to Ireland, the rest of Europe, the United States, and beyond. With a robust suite of services designed to meet clients' specific needs, ICON remains a key player in the clinical research landscape.